Education
About Us
Working with TipRanks
Follow Us
Primo Nutraceuticals Inc. (BUGVF)
:BUGVF
BUGVF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.11 - $0.11
Previous CloseN/A
Volume1.67K
Average Volume (3M)0.00
Market Cap
$26.00
Enterprise ValueN/A
Total Cash (Recent Filing)$9.95K
Total Debt (Recent Filing)C$465.93K
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding25,982,025
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio>-0.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BUGVF FAQ
What was Primo Nutraceuticals Inc.’s price range in the past 12 months?
Primo Nutraceuticals Inc. lowest stock price was $0.11 and its highest was $0.11 in the past 12 months.
What is Primo Nutraceuticals Inc.’s market cap?
Primo Nutraceuticals Inc.’s market cap is $26.00.
When is Primo Nutraceuticals Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Primo Nutraceuticals Inc.’s earnings last quarter?
Primo Nutraceuticals Inc. released its earnings results on Feb 20, 2020. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.007.
Is Primo Nutraceuticals Inc. overvalued?
According to Wall Street analysts Primo Nutraceuticals Inc.’s price is currently Overvalued.
Does Primo Nutraceuticals Inc. pay dividends?
Primo Nutraceuticals Inc. does not currently pay dividends.
What is Primo Nutraceuticals Inc.’s EPS estimate?
Primo Nutraceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Primo Nutraceuticals Inc. have?
Primo Nutraceuticals Inc. has 25,982,025 shares outstanding.
What happened to Primo Nutraceuticals Inc.’s price movement after its last earnings report?
Primo Nutraceuticals Inc. reported an EPS of -$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Primo Nutraceuticals Inc.?
Currently, no hedge funds are holding shares in BUGVF
Company Description
Primo Nutraceuticals Inc.
Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.
Technical Analysis
cbdMD
―
Cosmos Holdings
―
Flora Growth
―
Incannex Healthcare Limited Sponsored ADR
―
Akanda Corp
―